Company Profile:

HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Recent News:

On Dec. 10, 2018, the company announced that it has agreed to sell 15,000,000 shares of its common stock, consisting of 2,000,000 shares offered directly by the Company and 13,000,000 shares offered on a forward basis in connection with the forward sale agreement described below, at a price of $28.90 per share.

On Oct. 31, 2018, the company announced that S&P Global Ratings (“S&P”) upgraded its corporate credit rating to BBB+ from BBB, with a stable outlook.

Fundamental Analysis:

Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency.

Growth – Measures the growth of both the company’s income statement and cash flow.

@@@@@

Profitability – Measures the historical price movement of the stock.

@@@@@

Solvency – Measures the solvency of the company based on several ratios.

@@@@@

Efficiency – Measures the strength and historic growth of a company’s return on invested capital.

@@@@@

Conclusion:

HCP’s strengths can be seen in its better growth and strong profitability compared with its peers. Technical indicators signal the bullish signs, as there is a bullish crossover in Stochastic oscillator, , the MACD is trying to cross back up and the RSI stands at 47.72 with positive bias. We rate HCP, Inc. (HCP) a STRONG BUY.